Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3033 |
|
| Actual shortage: | 243 (8%) | |
| Anticipated shortage: | 15 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2766 (91%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
32 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Resolved | 2018-01-03 | 2018-02-12 | 34844 |
| APO-LEVOFLOXACIN | 250MG | TABLET | Resolved | 2018-01-18 | 2018-08-09 | 36450 |
| APO-CIPROFLOX | 250MG | TABLET | Resolved | 2018-01-31 | 2018-09-09 | 37729 |
| APO-TERBINAFINE | 250MG | TABLET | Resolved | 2018-01-31 | 2018-09-21 | 37746 |
| APO-NAPROXEN | 250MG | TABLET | Resolved | 2018-02-01 | 2018-04-05 | 37971 |
| APO-TERBINAFINE | 250MG | TABLET | Resolved | 2018-02-01 | 2018-04-15 | 37989 |
| APO-CEFUROXIME | 250MG | TABLET | Resolved | 2018-02-05 | 2018-04-14 | 38505 |
| APO-NAPROXEN EC TABLETS | 250MG | TABLET (ENTERIC-COATED) | Resolved | 2018-02-21 | 2018-05-01 | 40351 |
| APO-LEVETIRACETAM | 250MG | TABLET | Resolved | 2018-03-05 | 2018-06-08 | 41852 |
| APO-DEFERASIROX | 250MG | TABLET FOR SUSPENSION | Resolved | 2018-03-13 | 2018-07-03 | 42717 |
| APO-AMOXI | 250MG | POWDER FOR SUSPENSION | Resolved | 2018-03-27 | 2018-04-24 | 44099 |
| APO-MYCOPHENOLATE | 250MG | CAPSULE | Resolved | 2018-05-08 | 2018-09-11 | 48841 |
| APO-AZITHROMYCIN Z | 250MG | TABLET | Resolved | 2018-05-15 | 2019-02-21 | 49481 |
| APO-NAPROXEN EC TABLETS | 250MG | TABLET (ENTERIC-COATED) | Resolved | 2018-07-04 | 2018-12-28 | 54297 |
| APO-FAMCICLOVIR | 250MG | TABLET | Resolved | 2018-07-11 | 2018-08-09 | 55276 |
| APO-NAPROXEN | 250MG | TABLET | Resolved | 2018-08-09 | 2018-10-26 | 57799 |
| APO-LEVOFLOXACIN | 250MG | TABLET | Resolved | 2018-08-27 | 2019-01-02 | 59292 |
| APO-FAMCICLOVIR | 250MG | TABLET | Resolved | 2018-09-04 | 2018-12-18 | 59816 |
| APO-MYCOPHENOLATE | 250MG | CAPSULE | Resolved | 2018-10-11 | 2019-06-08 | 63796 |
| APO-LEVETIRACETAM | 250MG | TABLET | Resolved | 2018-10-19 | 2019-01-10 | 64938 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71032 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71035 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71038 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71044 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71048 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71051 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71057 | ||
| ACID CONTROL | Discontinued | 2019-01-04 | 2019-01-04 | 71198 | ||
| APO-RIZATRIPTAN RPD | Discontinued | 2019-01-04 | 2019-04-04 | 71334 | ||
| APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78141 | ||
| APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78144 | ||
| APO-ALMOTRIPTAN | Discontinued | 2019-05-13 | 2019-05-13 | 83971 | ||
| APO-ALMOTRIPTAN | Discontinued | 2019-05-13 | 2019-05-13 | 83976 | ||
| APO-AMOXI CLAV 250MG/62.5MG PER 5ML | Discontinued | 2019-05-13 | 2019-05-13 | 83981 | ||
| APO-AMOXI CLAV | Discontinued | 2019-05-17 | 2019-05-18 | 84392 | ||
| APO-CEFPROZIL | Discontinued | 2019-05-17 | 2019-05-18 | 84396 | ||
| APO-CEFPROZIL | Discontinued | 2019-06-12 | 2019-06-12 | 86542 | ||
| APO-CIPROFLOX | Discontinued | 2019-06-12 | 2019-06-12 | 86547 | ||
| APO-EXEMESTANE | Discontinued | 2019-06-12 | 2019-06-12 | 86552 | ||
| APO-GEMFIBROZIL CAP 300MG USP | Discontinued | 2019-06-12 | 2019-06-12 | 86557 |